Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028064 |
---|---|
Receipt number | R000032130 |
Scientific Title | The association of erythropoiesis-stimulating agent resistance index (ERI), serum fetuin-A with butyrylcholinesterase in hemodialysis patients |
Date of disclosure of the study information | 2017/07/06 |
Last modified on | 2022/12/05 22:33:59 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/07/04 13:00:22 | ||
2 | Update | 2017/11/03 22:29:58 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
3 | Update | 2017/11/04 13:25:03 | Recruitment status Results Results |
|
4 | Update | 2017/12/15 22:29:23 | Public title Public title Acronym Acronym |
|
5 | Update | 2017/12/15 22:31:33 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
6 | Update | 2017/12/15 22:32:59 | Results |
|
7 | Update | 2018/03/31 11:16:32 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2018/07/05 09:05:57 | Recruitment status |
|
9 | Update | 2018/07/05 09:07:34 | Publication of results URL related to results and publications |
|
10 | Update | 2018/07/05 09:12:30 | Recruitment status |
|
11 | Update | 2022/12/05 22:22:47 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Organization Organization Zip code Address Address TEL Name of person sending information Address3 Tel3 Email3 Organization Organization Address Address Tel |
|
12 | Update | 2022/12/05 22:26:40 | Date of IRB Other related information |
|
13 | Update | 2022/12/05 22:33:31 | URL releasing protocol Number of participants that the trial has enrolled Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
14 | Update | 2022/12/05 22:33:59 | Recruitment status |